“The U.S. Food and Drug Administration (FDA) has issued an alert that 471,000 mislabeled syringes for diabetics being recalled from Wal-Mart and Sam’s Clubs stores pose risk of insulin overdose.

The agency warned patients and health care professionals not to use disposable 31-gauge, 1cc ReliOn syringes with Lot Number 813900 as its manufacturer, Tyco Healthcare Group LP (Covidien), recalled the product on Oct. 9, 2008 and Wal-Mart notified buyers to return them in exchange for replacements. The said syringes were sold at Wal-Mart and Sam’s Clubs stores from Aug. 1, 2008 to Oct. 8, 2008.

The syringes being recalled are for use with U-40 insulin but were packed in boxes of syringes for use with U-100 insulin.”

~source

Post from: Blisstree

Syringe Recall From Sam’s and Wal-mart

A new study found that using an insulin pen may result in fewer trips to the emergency department and to the doctor’s office, resulting in substantial savings to diabetics and their insurers.

How does $17,000 in savings grab you? Uh huh, I said 17 thousand. Switching from insulin to an insulin pen could save you just that amount. The insulin pen is more accurate in that it gives a specific measured amount, meaning less chance of a mistake. We all know that mistakes with insulin often lead to doctor and hospital visits, so this would put you in the green.

We also know that there is a drawback with almost everything that goes along with health care. What is the issue here? The initial cost of “pen users” compared with “syringe users” is higher. And when the annual cost of prescriptions of both were compared, the pen was a slight bit higher. But I urge you to look past the before mentioned and think of the long term positive findings. Less hospitalizations, less doctors visits, less complications and a much happier diabetic!

via Science Daily

Post from: Blisstree

Savings Found Among Insulin Pen Users